Cowen and Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,500
Closed -$12K 779
2022
Q2
$12K Buy
+12,500
New +$1.64M ﹤0.01% 456
2021
Q4
Sell
-36,200
Closed -$152K 770
2021
Q3
$152K Buy
+36,200
New +$4.78M 0.01% 283
2020
Q3
Sell
-20,000
Closed -$9K 526
2020
Q2
$9K Buy
+20,000
New +$1.97M ﹤0.01% 366
2020
Q1
Sell
-68,800
Closed -$136K 540
2019
Q4
$136K Buy
68,800
+18,800
+38% +$1.81M 0.01% 241
2019
Q3
$137K Buy
+50,000
New +$4.57M 0.03% 266

Other funds holding XLV

Cowen and Company's XLV Position: Q4 2021 in Review

Cowen and Company sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2021, closing a stake of 369,986 shares — an estimated $47.1M sold.

Cowen and Company first reported a position in XLV in Q3 2019 and held it in 6 quarters. The position peaked at $47.1M in Q3 2021. 1,445 funds tracked by Wall St. Rank hold XLV as of Q4 2021.

  • Cowen and Company reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2021 after selling out during the quarter.
  • Cowen and Company sold 369,986 State Street Health Care Select Sector SPDR ETF shares in Q4 2021, an estimated $47.1M.
  • Cowen and Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2019 and held it in 6 quarters.
  • Cowen and Company's State Street Health Care Select Sector SPDR ETF position peaked at $47.1M in Q3 2021.
  • 1,445 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2021.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.